Joel Lewis insider trades: Galectin Therapeutics (GALT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Joel reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | GALT | ↓ Sell10b5-1 | 84,000 | $3.82 | $321K | Direct | Jan 6, 2026 (0d) |
| Dec 17, 2025 | GALT | ↓ Sell | 7,829 | $7.06 | $55K | Direct | Dec 19, 2025 (2d) |
| Nov 18, 2025 | GALT | ↓ Sell | 22,463 | $6.07 | $136K | Direct | Nov 19, 2025 (1d) |
| Nov 10, 2025 | GALT | ↓ Sell | 1,867 | $6.03 | $11K | Direct | Nov 12, 2025 (2d) |
| Nov 5, 2025 | GALT | ↓ Sell | 200 | $6.00 | $1K | Direct | Nov 7, 2025 (2d) |
| Nov 4, 2025 | GALT | ↓ Sell | 15,720 | $6.07 | $95K | Direct | Nov 5, 2025 (1d) |
| Sep 12, 2025 | GALT | ↓ Sell | 14,000 | $6.36 | $89K | Direct | Sep 15, 2025 (3d) |
| Dec 23, 2024 | GALT | ↓ Sell10b5-1 | 56,000 | $0.89 | $50K | Direct | Dec 26, 2024 (3d) |
| Apr 24, 2024 | GALT | ↑ Buy | 1,000 | $3.39 | $3K | as UTMA custodian for a minor child | Apr 25, 2024 (1d) |
| Feb 16, 2023 | GALT | ↑ Buy | 1,000 | $1.52 | $2K | as UTMA custodian for a minor child | Feb 21, 2023 (5d) |
| May 31, 2019 | GALT | ↑ Buy | 12,849 | $4.28 | $55K | Direct | Jun 3, 2019 (3d) |
| Apr 5, 2019 | GALT | ↑ Buy | 667 | $4.82 | $3K | Direct | Apr 8, 2019 (3d) |
| Feb 7, 2019 | GALT | ↑ Buy | 1,000 | $4.48 | $4K | Direct | Feb 11, 2019 (4d) |
| Jan 29, 2019 | GALT | ↑ Buy | 1,000 | $4.80 | $5K | Direct | Jan 30, 2019 (1d) |
| Jun 25, 2018 | GALT | ↑ Buy | 1,000 | $7.06 | $7K | Direct | Jun 26, 2018 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GALT insiders
Open-market trades in the last 12 months
About Joel Lewis's insider trades
Joel Lewis is President and CEO at Galectin Therapeutics (GALT). Since Jun 25, 2018, Joel has reported 7 open-market purchases worth $79K and 8 sales worth $759K on SEC Form 4. In the last 12 months: 4 sales ($524K).
2 sales (49% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (95 filings), option exercises (9 filings), shares withheld for taxes (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GALT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.